Viewing Study NCT00304447



Ignite Creation Date: 2024-05-05 @ 4:43 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00304447
Status: COMPLETED
Last Update Posted: 2009-07-29
First Post: 2006-03-15

Brief Title: Study Evaluating the Effect of Corticosteroids on Mylotarg Infusion-Related Adverse Events in Patients With Leukemia
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization: Wyeth is now a wholly owned subsidiary of Pfizer

Study Overview

Official Title: A Phase IV Study of Corticosteroids As Prophylaxis for Infusion-Related Adverse Events to Mylotarg in Patients With Acute Myelogenous Leukemia AML
Status: COMPLETED
Status Verified Date: 2009-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate the effect of corticosteroids on the frequency and severity of Mylotarg infusion-related adverse events to evaluate the effect of corticosteroids on the efficacy of Mylotarg induced complete response CR and complete response with incomplete platelet recovery CRp at one-month post treatment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None